Riese Richard J. 4
4 · SYNLOGIC, INC. · Filed Mar 12, 2021
Insider Transaction Report
Form 4
SYNLOGIC, INC.SYBX
Riese Richard J.
Chief Medical Officer
Transactions
- Award
Common Stock
2021-03-10+17,500→ 39,000 total - Award
Stock Option (right to buy)
2021-03-10+70,000→ 70,000 totalExercise: $3.50Exp: 2031-03-10→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]The shares of restricted stock were granted on March 10, 2021, and will vest beginning on April 1, 2021 (the "Vesting Start Date") in four equal annual installments on each anniversary of the Vesting Start Date, subject to the Reporting Person continuing to provide services to the Issuer as Chief Medical Officer through each such vesting date.
- [F2]The option will vest and become exercisable in equal monthly installments for forty-eight months beginning on April 1, 2021, with the first installment vesting on May 1, 2021 subject to the Reporting Person continuing to provide services to the Issuer as Chief Medical Officer through each such vesting date.